Spotlight session: Scaling up manufacturing for allogeneic cell therapies

Allogeneic cell therapies simplify certain aspects of early manufacturing but present unique hurdles when scaling to meet clinical and commercial demand. This session explores approaches to address these challenges, optimize production workflows, and ensure consistent product quality. 

Key takeaways: 

• Identify manufacturing challenges unique to allogeneic cell therapies 

• Evaluate strategies to maintain quality and reproducibility at scale 

• Explore methods to optimize early production processes for commercial readiness 

• Discuss process design considerations that balance efficiency with complexity 

• Assess approaches to support scalable, off-the-shelf therapy supply